tirzepatide alzheimer's alzheimer clinical trial Tirzepatide: a novel therapeutic approach for disease tirzepatide alzheimer's Tirzepatide: a novel

Do not stop treatment abruptly without medical guidance, as this may affect glycaemic control or weight management outcomes

Gastrointestinal discomfort experienced while taking these drugs should taper within a month of stopping

How to switch safely from Mounjaro to Wegovy Switching between these medications should follow a structured approach under medical supervision

"While GLP-1 medications provide powerful support for weight management, the degree of weight loss depends heavily on adherence to a modest caloric deficit below total daily energy expenditure and on engaging in regular physical activity to increase caloric utilization," he explains